# Quick Fix Reference - Statistical Audit Results

## The Problem (One Sentence)
Sharpe ratio metrics are inflated 100,000x because the code passes **dollar P&L** to empyrical instead of **percentage returns**.

## The Fix (One Line)

**File:** `src/analysis/metrics_empyrical.py`
**Line:** 38

Change this:
```python
returns = portfolio['portfolio_pnl']  # WRONG - Dollar P&L
```

To this:
```python
returns = portfolio['portfolio_return']  # RIGHT - Percentage returns
```

## Verification After Fix

After making the change, re-run a backtest and check:

```
Old (WRONG): Sharpe ratio = 1,000,000 or Infinity
New (RIGHT): Sharpe ratio = 0.5 to 3.0 (reasonable range)
```

## Why This Matters

- Current Sharpe ratios: **COMPLETELY INVALID** (inflated 100,000x)
- All trading decisions based on current metrics: **DO NOT TRUST**
- Strategy deployment: **BLOCKED until fixed**

## Timeline

- **Fix:** 5 minutes
- **Re-run backtests:** 2 hours
- **Full validation:** 2-3 weeks

## Files Created

- `AUDIT_EXECUTIVE_SUMMARY.txt` - Read this first (9 KB)
- `STATISTICAL_AUDIT_DETAILED.md` - Full technical analysis (12 KB)
- `STATISTICAL_AUDIT.json` - Machine-readable results (8.6 KB)

## Other Issues Found

1. **Regime sample sizes:** Breaking Vol (25 days), Compression (31 days) - too small
   - Impact: Low (medium priority, 6-9 month fix)

2. **Multiple testing:** ~107 tests with no correction mentioned
   - Impact: Low (apply Bonferroni if reporting p-values)

3. **Data quality:** Everything else checks out
   - Realized volatility: ✓
   - IV rank percentiles: ✓
   - Z-scores: ✓
   - Annualization factors: ✓
   - Walk-forward compliance: ✓

## Bottom Line

**DON'T DEPLOY based on current Sharpe metrics.**

Fix the one-line bug, re-run backtests, then re-evaluate with correct numbers.

---

## Reference: What Got Checked

- Empyrical library usage (found critical bug)
- Metrics calculations (Sharpe, Sortino, Calmar, etc.)
- Profile feature engineering (RV, IV rank, skew, etc.)
- Regime classification (frequency distribution, sample sizes)
- Sample size adequacy for statistical testing
- Multiple hypothesis testing corrections needed
- Annualization factors correctness
- Walk-forward compliance (no lookahead bias)
- Data quality and completeness

